undefined undefined
NaN.000
NaN.00%
Gainers: Sight Sciences (SGHT) +19%. Zapata Computing Holdings (ZPTA) +9%. Cal-Maine Foods (CALM) +6%. Vanda Pharmaceuticals (VNDA) +5%. iHeartMedia (IHRT) +5%. Losers: Acorda Therapeutics (ACOR) -9...
04-03 04:43
AC Immune SA Reported FY23 Revenue of CHF14.80M Vs CHF3.94M YoY, EPS Loss of CH...
03-14 19:17
AC Immune to Regain Global Rights to Crenezumab and Semorinemab Company's stra...
01-22 08:00
PDF Version 164.4 KB AC Immune Strengthens Management, Appoints Madih...
2023-12-01 01:00
AC Immune (NASDAQ:ACIU) reported quarterly losses of $(0.20) per share. This is a 20 percent decrease over losses of $(0.17) per share from the same period last year.
2023-11-03 19:07
转自:IQVIA艾昆纬 阿尔茨海默病(AD)是一种进行性神经退行性疾病,估计占失智症病例的60-80%。全球失智症的年度支出预计将从2021年的1.3万亿美...
2023-09-21 12:00
What is the target price for AC Immune (ACIU)?The latest price target for AC Im...
2023-08-07 18:13
《科创板日报》7月2日讯(实习记者 张真) 本周(6月26日至7月2日),医药行业重要动态包括: 国家卫健委发布“十四五”大型医用设备配置规划;国家医保局正式公...
2023-07-02 15:59
AC Immune SA (NASDAQ: ACIU) shares surged Tuesday after the company received FDA Fast Track Designation for its anti-amyloid-beta active immunotherapy, ACI-24.060,
2023-06-28 02:49
BDTX: 89% | Black Diamond Therapeutics Announces Initial Dose Escalation Data Demonstrating Anti-Tumor Activity of BDTX-1535 in Non-Small Cell Lung Cancer Patients Across Multiple EGFR Mutation Families CNTG:
2023-06-27 20:35